We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 2,203

High Court to be asked to consider patentability of BRCA genes

  • Watermark Patent & Trade Marks Attorneys
  • -
  • Australia
  • -
  • September 18 2014

Lawyers acting for the Appellant in the BRCA gene case have announced that they will seek special leave to appeal the decision to the High Court of

The thorny problem of patentable eligible subject matter: part 10 of a 10-part series: Japan

  • Michael Best & Friedrich LLP
  • -
  • Japan, USA
  • -
  • September 16 2014

The Japanese Patent Act (Act) contains two provisions regarding patent eligible subject matter. The first provision is found in Article 2(1) of the

The new patent policy on natural products is a game changer for universities and life sciences companies

  • Bradley Arant Boult Cummings LLP
  • -
  • USA
  • -
  • September 16 2014

Since the 19th Century, it has been considered a given that a person who identifies and purifies a useful natural substance is entitled to a patent

Full Federal Court upholds ‘gene patents’

  • Norton Rose Fulbright Australia
  • -
  • Australia
  • -
  • September 12 2014

A specially constituted 5 member Full Federal Court has unanimously upheld a patent which covers the isolated nucleic acid (RNA or DNA) of 'BRCA1'

Australian court finds human gene mutation to be patentable

  • Shook Hardy & Bacon LLP
  • -
  • Australia, USA
  • -
  • September 11 2014

A full panel of the Federal Court of Australia has upheld its earlier ruling that an isolated but naturally occurring nucleic acid, BRCA1, can be

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

The U.S. Patent and Trademark Office (USPTO) seeks comments on the estimated time burdens of revisions to a currently approved information collection

The thorny problem of patentable eligible subject matter: part 9 of a 10-part series: South Africa

  • Michael Best & Friedrich LLP
  • -
  • South Africa, USA
  • -
  • September 11 2014

In South Africa, patentable inventions are regulated by Section 25 of the Patents Act 57 of 1978 (Patents Act) as amended. Section 25 provides: (1) A

Nature's indelible marker

  • Dilworth IP
  • -
  • USA
  • -
  • September 11 2014

The pharmaceutical industry is an important segment of the world economy. In 2013, worldwide sales of prescription drugs were over $830 billion. If

Not just genes: Full Federal Court upholds decision about patentability of isolated DNA

  • Clayton Utz
  • -
  • Australia, USA
  • -
  • September 10 2014

On 5 September 2014, five judges of the Full Federal Court upheld a lower court's decision that isolated human DNA was patentable subject matter

Advocate General: the use of unfertilised human ova is patentable

  • De Brauw Blackstone Westbroek
  • -
  • European Union, Netherlands
  • -
  • September 10 2014

In International Stem Cell Corporation, the Advocate General of the European Court of Justice recently opined that parthenogenetically activated